Sep 16, 2022
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.15 to $0.01.
The split itself did not change the total investment value.
Nabriva Therapeutics plc (NBRV) trades on the NASDAQ Capital Market in the Biotechnology industry.
Nabriva Therapeutics plc company overviewThe latest split shown was on September 16, 2022. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records 3 splits between June 26, 2017 and September 16, 2022.
Already premium? Sign in